NYSE American - Delayed Quote USD

Zomedica Corp. (ZOM)

0.1330 +0.0029 (+2.23%)
At close: April 26 at 4:00 PM EDT
0.1338 +0.00 (+0.60%)
After hours: April 26 at 7:56 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Larry C. Heaton II President, CEO & Director 617.59k -- 1957
Mr. Peter L. Donato BSBA, M.B.A. Chief Financial Officer -- -- 1970
Mr. Anthony K. Blair Chief Operating Officer -- -- 1961
Mr. Evan St. Peter M.B.A. Vice President of Technology Innovation -- -- --
Ms. Karen L. DeHaan-Fullerton J.D. Chief Counsel & Corporate Secretary -- -- 1969
Ms. Nicole Westfall M.B.A. Senior Vice President of Marketing -- -- --
Mr. Russell Kevin Klass Senior Vice President of Sales -- -- --
Ms. Kristin Domanski Vice President of Human Resources -- -- --
Mr. Greg Blair Senior Vice President of Business Development & Strategic Planning -- -- --
Mr. Robert W. DiMarzo Consultant 291.2k -- 1957

Zomedica Corp.

100 Phoenix Drive
Suite 190
Ann Arbor, MI 48108
United States
734 369 2555 https://www.zomedica.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
144

Description

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.

Corporate Governance

Zomedica Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 09, 2024 - May 13, 2024
Zomedica Corp. Earnings Call

Related Tickers

SENS Senseonics Holdings, Inc.
0.4157
-0.60%
 
BIOL BIOLASE, Inc.
0.1480
0.00%
 
SINT Sintx Technologies, Inc.
0.0404
+10.38%
 
ASXC Asensus Surgical, Inc.
0.2490
+3.32%
 
NUWE Nuwellis, Inc.
0.1678
-41.94%
 
HSCS Heart Test Laboratories, Inc.
0.0974
-2.50%
 
CATX Perspective Therapeutics, Inc.
1.5800
-1.25%
 
NSPR InspireMD, Inc.
2.0000
+5.82%
 
DYNT Dynatronics Corporation
0.5549
-3.53%
 
PACB Pacific Biosciences of California, Inc.
1.4700
+6.52%